We provide flexible manufacturing of pre-clinical reference proteins and monoclonal antibodies services - tailor to project-specific requirements - that are implemented by a team with industry experience. The CHO-C platform provides GMP grade cell lines with a competitive timeline that accelerates preclinical studies for new drugs. From Proprietary expression vectors, cGMP host cells to Proprietary media the first Taiwanese CHO cell production platform was established with advanced processes. The CHO-C cell expression system is suitable for developing new drugs. Notably, it accelerates the pre-clinical studies and lowers the development cost for cell line development and protein production services.
We provide flexible manufacturing of pre-clinical reference proteins and monoclonal antibodies servi…more...